Goosehead Insurance (GSHD) stock rises 8.2% after reporting strong Q2 results and announcing a CEO succession plan. Strong Q2 results lift near-term financial outlook while CEO succession secures leadership continuity and strategy execution.
| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | 1 | 2 | — | — | 1 | — | — | 5 | — | 3 | — | — |
| Sell | — | — | 1 | — | — | — | 1 | 5 | — | 3 | 4 | — |
| total | individual payouts | |
|---|---|---|
| 2027 | ‡‡‡‡ |
|
| 2026 | ‡‡‡‡ |
|
| 2025 | 5.91 |
—
|
| 2024 | ‡‡‡‡‡ |
|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | 0.00 |
—
|
| 2020 | 1.15 |
—
|
| 2019 | 0.00 |
—
|
| 2018 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 44.05 | 57.97 | 37.94 | 27.49 |
| Receivables | 22.62 | 42.45 | 47.75 | 43.26 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 74.56 | 108.56 | 93.24 | 85.36 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 16.40 | 22.89 | 33.63 | 30.12 |
| ST’ Debt | — | — | — | — |
| Other | 4.13 | 3.28 | 9.48 | 9.03 |
| 40.89 | 46.46 | 58.31 | 55.27 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | — | ‡‡‡ | ‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 93.08 | 113.39 | — | — |
—
|
| ’25 | 75.58 | 94.03 | 90.44 | 105.26 |
365.30
|
| ’24 | 64.46 | 78.09 | 78.04 | 93.92 |
314.51
|
| ’23 | 57.96 | 69.28 | 71.03 | 63.01 |
261.28
|
| ’22 | 41.28 | 53.02 | 57.69 | 57.40 |
209.39
|
| ’21 | 31.23 | 38.17 | 41.68 | 40.23 |
151.31
|
| ’20 | 20.43 | 29.92 | 32.02 | 34.65 |
117.01
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 22.87 | 15.93 | — | — |
—
|
| ’25 | 15.48 | 28.91 | 24.21 | 23.15 |
91.76
|
| ’24 | 12.07 | 18.88 | 28.10 | 12.50 |
71.54
|
| ’23 | (0.64) | 16.86 | 21.15 | 13.46 |
50.83
|
| ’22 | (5.15) | 15.25 | 22.93 | 3.02 |
36.03
|
| ’21 | 7.89 | 12.10 | 6.81 | 8.64 |
35.44
|
| ’20 | (1.47) | 7.99 | 8.53 | 9.60 |
24.64
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 15.79 | 8.79 | — | — |
—
|
| ’25 | 12.13 | 24.25 | 20.02 | 16.58 |
72.99
|
| ’24 | 9.29 | 16.00 | 24.74 | 9.34 |
59.36
|
| ’23 | (3.18) | 13.37 | 18.58 | 9.91 |
38.68
|
| ’22 | (7.65) | 10.92 | 12.88 | 7.27 |
23.42
|
| ’21 | 5.78 | 4.91 | 5.94 | 3.40 |
20.04
|
| ’20 | (2.50) | 4.91 | 7.55 | 4.32 |
14.28
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.19 | 0.41 | — | — |
—
|
| ’25 | 0.09 | 0.18 | 0.29 | 0.48 |
1.04
|
| ’24 | 0.05 | 0.24 | 0.29 | 0.57 |
1.15
|
| ’23 | 0.00 | 0.15 | 0.28 | 0.14 |
0.55
|
| ’22 | (0.11) | 0.02 | 0.09 | 0.02 |
0.03
|
| ’21 | (0.02) | 0.07 | 0.19 | 0.01 |
0.26
|
| ’20 | (0.01) | 0.19 | 0.17 | 0.14 |
0.51
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 29.23 | 31.21 | 50.47 | 64.41 | — | — | — |
Low Price
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 133.11 | 79.80 | 130.39 | 127.99 | — | — | — |
High Price
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,427 | 1,415 | 1,580 | 1,600 | — | — | — |
Employees
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.15 | 0.18 | 0.20 | 0.23 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 209.39 | 261.28 | 314.51 | 365.30 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 100.00% | 100.00% | 100.00% | 100.00% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.13 | 26.39 | 46.70 | 50.85 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.45% | 10.10% | 14.85% | 13.92% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.63 | 23.70 | 49.11 | 44.45 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.11 | 9.47 | 10.96 | 12.41 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.97 | 10.92 | 12.76 | 14.63 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | — | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 0.03 | 0.59 | 1.23 | 1.11 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.72 | 2.12 | 2.90 | 3.67 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.60) | (0.51) | (0.49) | (0.75) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.12 | 1.62 | 2.41 | 2.92 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.60) | 0.70 | 1.58 | (6.52) | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.00 | 23.93 | 24.66 | 24.98 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,762.50 | 124.76 | 87.17 | 66.95 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.53 | 6.74 | 8.41 | 5.04 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 104.93 | 67.66 | 0.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.87 | 6.90 | 8.54 | 5.77 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 34.58 | 46.60 | 45.24 | 28.89 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 36.03 | 50.83 | 71.54 | 91.76 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (12.61) | (12.16) | (12.19) | (18.77) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.42 | 38.68 | 59.36 | 72.99 | ‡‡‡‡‡ | — | — |
FCF
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.96 | 33.67 | 62.11 | 34.93 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 100.21 | 67.56 | 82.25 | 289.46 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 69.83 | 23.52 | 24.28 | 251.52 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (33.62) | 16.79 | 39.08 | (162.79) | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.19% | 4.18% | 8.09% | 6.85% | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.49% | 51.11% | 60.32% | 52.44% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.10%) | (167.95%) | 108.93% | (44.99%) | ‡‡‡‡‡ | — | — |
ROE
|
Goosehead Insurance (GSHD) has delivered explosive revenue growth, surging 889% from $31.5 million in 2016 to $314.5 million in 2024 at a 34% CAGR, powered by a franchise model that expanded employee headcount 461% and boosted revenue per employee 566%. With consistent 100% gross margins and free cash flow per share up 638% to $2.41, operational efficiency shines through a 0.95 correlation between revenue and headcount growth. Post-IPO volatility tested profitability—marked by a 2018 net loss and 2022 dips amid rate hikes—but a sharp turnaround emerged, with net income hitting $49.1 million in 2024, ROE at 108.9%, and EBT margins expanding to 14.9% (145% 3-year CAGR).
Stock performance mirrors this rollercoaster, rebounding 309% from 2022 lows to $130 highs, with PS ratios compressing to 8.4x and PE at 87x amid earnings catch-up. Analyst projections fuel optimism: 19% revenue CAGR to $525 million by 2027, EPS to $2.20 (56% terminal growth), and EV/sales dropping to 2.5x, implying 63% mean upside (high of 187%) from current levels. Monte Carlo simulations peg a 70% probability of 15-25% annualized returns through 2027 if agent retention exceeds 90%.
Recent executive insider buys—CEO, CFO, and GC adding shares worth $676k at dips—signal confidence amid $66.8 million in 10% owner sells, a common post-IPO pattern. Risks like debt sensitivity and competition loom, but opportunities in AI quoting and housing recovery support a high-conviction outlook: 65% odds of doubling in three years. Dive into the full analysis for regression models, DCF details, and Q1 2026 catalysts.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.